[An anti-human eosinophil monoclonal antibody AE500 that reacts only with granulocytes from hypereosinophilic patients]. 1990

K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
Second Department of Internal Medicine, Chiba University School of Medicine.

To investigate the heterogeneity of human eosinophils, we established a murine anti-human eosinophil monoclonal antibody AE500 (IgM, kappa) by immunizing blood eosinophils from patients with idiopathic eosinophilia. The reactivity of AE500 with human leukocytes was analyzed by a fluorescence-activated cell sorter. AE500 reacted with all the populations of blood eosinophils and neutrophils from patients with eosinophilia (idiopathic eosinophilia, n X 4 or asthma, n =), but not with those from asthmatic patients without eosinophilia (n = 8) or normal subjects (n = 6). AE500 did not react with granulocytes from other family members of AE500-positive individuals. These results suggest that the anti-human eosinophil antibody AE500 reacts with a cell surface antigen of blood granulocytes in a hypereosinophilic state. This anti-eosinophilic antibody would be useful in investigating the mechanism of eosinophilia in a variety of diseases.

UI MeSH Term Description Entries
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
January 1987, Natural immunity and cell growth regulation,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
August 1983, FEBS letters,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
January 1988, International archives of allergy and applied immunology,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
January 1984, Immunology letters,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
May 2004, Protein expression and purification,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
January 2006, Placenta,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
October 1985, Molecular immunology,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
April 1982, Science (New York, N.Y.),
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
January 2016, mAbs,
K Ochiai, and I Iwamoto, and A Kimura, and N Nakagawa, and H Tomioka, and S Yoshida, and H Takahashi, and A Yoshida
January 1985, Human immunology,
Copied contents to your clipboard!